40
Participants
Start Date
October 1, 2018
Primary Completion Date
May 30, 2019
Study Completion Date
September 30, 2019
BFPET
Sterile study drug will be delivered in individual dosage vials labeled and calibrated to approximately 2 mCi (74MBq) for the rest imaging and up to 8 mCi (296 MBq) for the stress imaging at the time of injection. The drug will be administered intravenously by bolus injection over 10 seconds into a peripheral vein to which access has been secured followed by saline flush.
Massachusetts General Hospital, Boston
Lead Sponsor
Fluoropharma, Inc.
INDUSTRY